LB Pharmaceuticals

tenant

drug

Mindfulness-based therapy

as of 2026-07-01

Add to landscape Monitor this Compare this Ask about this

at a glance

BEHAVIORAL

Pre-approval / investigational in the US

Developed by Butler Hospital

1 trials in the graph

Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality

BEHAVIORAL

Indications

Investigational (via trials)

Schizophrenia Bipolar Disorder Schizophrenia Depressive Disorder, Major Major Depressive Disorder Serious Mental Illness Bipolar Disorder

Trials

1

Mindfulness-Based Therapy for Serious Mental Illness

NCT06880796—Enrolling By Invitation

KOLs & investigators

1

Brandon Gaudiano, PhD

Facts & assertions

0 sourced

No assertions recorded for this entity.

relationships

The graph out of here

developer

Butler Hospital

company

trial

Mindfulness-Based Therapy for Serious Mental Illness

NA

trial

indication

indication

Bipolar Disorder

indication

indication

Depressive Disorder, Major

indication

KOL

Brandon Gaudiano, PhD

KOL score —

person